Cagrilintide

1. Product Name
Cagrilintide Peptide Vial
 
2. Chemical Name
Cagrilintide — a synthetic, long-acting acylated analogue of human amylin.
 
3. CAS Number
1415456-99-3
 
4. Researched Benefits of the Peptide
Cagrilintide is an investigational peptide studied for its prolonged activation of amylin receptors, which are involved in appetite regulation, satiety and energy intake. Its potential effects have been evaluated in clinical trials, both alone and in combination with semaglutide.
Established mechanism: Designed to mimic the activity of amylin, a pancreatic peptide hormone associated with satiety and the regulation of food intake.
Human clinical research: Randomised trials have reported reductions in body weight among adults with overweight or obesity compared with placebo.
Combination research: Cagrilintide has been studied with semaglutide under the investigational name CagriSema, with clinical trials reporting greater average weight reduction than placebo.
Metabolic research: Ongoing studies are examining its potential relevance to body-weight regulation and glycaemic markers in participants with and without type 2 diabetes.
 
6. KIT INCLUDES:
1x Peptide Vial
1x 10ml BAC water
1x Reconstitution Kit
For research use only. Not for human consumption.